{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T14:50:43Z","timestamp":1785682243442,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["humanpathol.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Pathology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.humpath.2015.09.015","type":"journal-article","created":{"date-parts":[[2015,10,3]],"date-time":"2015-10-03T06:08:34Z","timestamp":1443852514000},"page":"26-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas"],"prefix":"10.1016","volume":"47","author":[{"given":"Drew G.","family":"Davis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momin T.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Oprea-Ilies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxian (Bill)","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humpath.2015.09.015_bb0005","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1309\/AJCP8H2VBDSCIOBF","article-title":"Immunoreactivity in breast, bladder, gynecologic tract, and other cytokeratin 7-positive carcinomas","volume":"142","author":"Clark","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0010","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1309\/AJCP0Q9UQTEESLHN","article-title":"Immunohistochemical expression in ER-negative breast carcinomas","volume":"141","author":"Liu","year":"2014","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0015","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1002\/(SICI)1097-0215(19990420)84:2<122::AID-IJC5>3.0.CO;2-S","article-title":"GATA-3 is expressed in association with estrogen receptor in breast cancer","volume":"84","author":"Hoch","year":"1999","journal-title":"Int J Cancer"},{"key":"10.1016\/j.humpath.2015.09.015_bb0020","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","article-title":"Molecular portraits of human breast tumours","volume":"406","author":"Perou","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.humpath.2015.09.015_bb0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/ncb1530","article-title":"Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation","volume":"9","author":"Asselin-Labat","year":"2007","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1309\/AJCP5UAFMSA9ZQBZ","article-title":"Immunohistochemical evaluation of GATA-3 expression in tumors and normal tissues: a useful immunomarker for breast and urothelial carcinomas","volume":"138","author":"Liu","year":"2012","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/PAS.0b013e3182a0218f","article-title":"GATA-3: a multispecific but potentially useful marker in surgical pathology: a systematic analysis of 2500 epithelial and nonepithelial neoplasms","volume":"38","author":"Miettinen","year":"2014","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.2002.0780","article-title":"Forkhead transcription factors: key players in development and metabolism","volume":"250","author":"Carlsson","year":"2002","journal-title":"Dev Biol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0045","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1210\/me.2005-0334","article-title":"Estrogen receptor target gene: an evolving concept","volume":"20","author":"Carroll","year":"2006","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0050","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cell.2005.05.008","article-title":"Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FOXA1","volume":"122","author":"Carroll","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.humpath.2015.09.015_bb0055","doi-asserted-by":"crossref","first-page":"11651","DOI":"10.1073\/pnas.0505575102","article-title":"Location analysis of estrogen receptor \u03b1 target promoters reveals that FOXA1 defines a domain of the estrogen response","volume":"102","author":"Laganiere","year":"2005","journal-title":"PNAS"},{"key":"10.1016\/j.humpath.2015.09.015_bb0060","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1136\/jcp.2007.052431","article-title":"Forkhead box A1 expression in breast cancer is associated with luminal subtype and good prognosis","volume":"61","author":"Thorat","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0065","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/modpathol.2009.172","article-title":"Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence score","volume":"23","author":"Ademuyiwa","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0070","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.gde.2010.06.005","article-title":"The FoxA factors in organogenesis and differentiation","volume":"20","author":"Kaestner","year":"2010","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.humpath.2015.09.015_bb0075","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7150\/ijbs.8389","article-title":"Modulation of androgen receptor by FOXA1 and FOXO1 factors in prostate cancer","volume":"10","author":"Zhao","year":"2014","journal-title":"Int J Biol Sci"},{"key":"10.1016\/j.humpath.2015.09.015_bb0080","series-title":"Handbook of practical immunohistochemistry: frequently asked questions","first-page":"45","article-title":"Tissue microarray","author":"Wilkerson","year":"2011"},{"key":"10.1016\/j.humpath.2015.09.015_bb0085","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gynor.2012.12.008","article-title":"Metastatic ovarian papillary serous carcinoma to the breast: diagnosis and pitfalls","volume":"4","author":"Mhawech-Fauceglia","year":"2013","journal-title":"Gynecol Oncol Case Rep"},{"key":"10.1016\/j.humpath.2015.09.015_bb0090","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.humpath.2012.11.003","article-title":"GATA-3 expression in breast carcinoma: utility in triple-negative, sarcomatoid, and metastatic carcinomas","volume":"44","author":"Cimino-Matthews","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0095","article-title":"Impact of GATA-3 and FOXA1 expression in patients with hormone receptor-positive\/HER2-negative breast cancer","volume":"1\u20139","author":"Hisamatsu","year":"2014","journal-title":"Breast Cancer"},{"key":"10.1016\/j.humpath.2015.09.015_bb0100","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.humpath.2014.03.015","article-title":"GATA-3 expression in sarcomatoid urothelial carcinoma of the bladder","volume":"45","author":"Fatima","year":"2014","journal-title":"Hum Pathol"},{"key":"10.1016\/j.humpath.2015.09.015_bb0110","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/ncomms4972","article-title":"Cooperativity and equilibrium with FOXA1 define the androgen receptor transcriptional program","volume":"5","author":"Jin","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.humpath.2015.09.015_bb0115","doi-asserted-by":"crossref","first-page":"e42456","DOI":"10.1371\/journal.pone.0042456","article-title":"FOXA1 promotes tumor progression in prostate cancer via the insulin-like growth factor binding protein 3 pathway","volume":"7","author":"Imamura","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.09.015_bb0120","doi-asserted-by":"crossref","first-page":"R40","DOI":"10.1186\/bcr2327","article-title":"Expression of FOXA1 and GATA-3 in breast cancer: the prognostic significance in hormone receptor-negative tumors","volume":"11","author":"Albergaria","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.humpath.2015.09.015_bb0125","doi-asserted-by":"crossref","first-page":"e36669","DOI":"10.1371\/journal.pone.0036669","article-title":"Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferation","volume":"7","author":"DeGraff","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.humpath.2015.09.015_bb0130","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/j.humpath.2014.03.006","article-title":"Diagnostic utility of immunohistochemistry in distinguishing between epithelioid pleural mesotheliomas and breast carcinomas: a comparative study","volume":"45","author":"Ord\u03cc\u00f1ez","year":"2014","journal-title":"Hum Pathol"}],"container-title":["Human Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003585?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0046817715003585?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T23:29:44Z","timestamp":1537313384000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0046817715003585"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S0046817715003585"],"URL":"https:\/\/doi.org\/10.1016\/j.humpath.2015.09.015","relation":{},"ISSN":["0046-8177"],"issn-type":[{"value":"0046-8177","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GATA-3 and FOXA1 expression is useful to differentiate breast carcinoma from other carcinomas","name":"articletitle","label":"Article Title"},{"value":"Human Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humpath.2015.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}